Fetal supraventricular tachycardia and maternal COVID-19 vaccination: is there any relationship?

Wael Abdallah; Johnny B Rechdan; Razane Lakkis; Malek Nassar; Linda Daou; Nadine El Kassis; David Atallah

doi:10.2144/fsoa-2022-0007

Fetal supraventricular tachycardia and maternal COVID-19 vaccination: is there any relationship?

Future Sci OA. 2022 Sep 12;8(7):FSO812. doi: 10.2144/fsoa-2022-0007. eCollection 2022 Aug.

Authors

Wael Abdallah¹, Johnny B Rechdan², Razane Lakkis¹, Malek Nassar¹, Linda Daou³, Nadine El Kassis¹, David Atallah¹

Affiliations

¹ Department of Gynecology & Obstetrics, Hôtel-Dieu de France University Hospital, Saint Joseph University, Beirut, 116-5137, Lebanon.
² Department of Gynecology & Obstetrics, Lebanese American University Medical Center, Lebanese American University, Beirut, 116-5137, Lebanon.
³ Department of Pediatrics, Hôtel-Dieu de France University Hospital, Saint Joseph University, Beirut, 116-5137, Lebanon.

Abstract

Fetal supraventricular tachycardia accounts for 60-80% of the fetal tachyarrhythmias with prevalence ranging from 1/1000 to 1/25 000 pregnancies. It may be secondary to fetal anomalies or maternal factors. By reviewing the literature, there is no previous article that reports fetal arrhythmia after maternal vaccination. We present herein two cases of fetal supraventricular tachycardia following the administration of the Pfizer-BioNTech COVID-19 vaccine during pregnancy. Continued safety monitoring and more longitudinal follow-up are needed to evaluate the fetal impact after maternal COVID-19 vaccination.

Keywords: COVID-19 vaccine; fetal arrhythmia; pregnancy; supraventricular tachycardia.

Publication types

Case Reports